Fig. 4.
Actuarial probability of surviving in cytogenetic remission.
(A) The 9-year actuarial probability of surviving in cytogenetic remission for patients with positive p190BCR-ABL or negative P190BCR-ABL. (B) Actuarial probability of surviving in cytogenetic remission for patients with myeloid MC versus patients with myeloid DC.